Profile
Michael Stowell is the founder of AmideBio LLC, where he currently holds the title of Chief Scientific Officer & Director since 2009.
He was a Scientific Advisor at Clarimedix, Inc. and a Professor at The University of Colorado.
Dr. Stowell received his undergraduate degree from The Reed Institute and his doctorate from the California Institute of Technology.
Michael Stowell active positions
Companies | Position | Start |
---|---|---|
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Founder | 2008-12-31 |
Former positions of Michael Stowell
Companies | Position | End |
---|---|---|
The University of Colorado | Corporate Officer/Principal | - |
Clarimedix, Inc.
Clarimedix, Inc. Medical SpecialtiesHealth Technology Clarimedix, Inc. develops pipeline products for diseases associated with vascular dysfunction. It offers products for the treatment of cerebral vasospasm, raynaud’s syndrome and alzheimer’s disease. Clarimedix was founded in 2006 and was headquartered in Aurora, CO. | Corporate Officer/Principal | - |
Training of Michael Stowell
The Reed Institute | Undergraduate Degree |
California Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Clarimedix, Inc.
Clarimedix, Inc. Medical SpecialtiesHealth Technology Clarimedix, Inc. develops pipeline products for diseases associated with vascular dysfunction. It offers products for the treatment of cerebral vasospasm, raynaud’s syndrome and alzheimer’s disease. Clarimedix was founded in 2006 and was headquartered in Aurora, CO. | Health Technology |
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Health Technology |
- Stock Market
- Insiders
- Michael Stowell